Similar efficacy of lopinavir/ritonavir-containing regimens among clades B and F HIV-1-Infected individuals in Brazil

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):399-401. doi: 10.1097/qai.0b013e31815b0d48.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brazil
  • CD4 Lymphocyte Count
  • Drug Combinations
  • Drug Resistance, Multiple / genetics
  • Drug Resistance, Viral / genetics
  • Genotype
  • HIV Infections / blood
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • Humans
  • Lopinavir
  • Mutation
  • Prospective Studies
  • Pyrimidinones / therapeutic use*
  • RNA, Viral / blood
  • RNA, Viral / genetics
  • Ritonavir / therapeutic use*
  • Time
  • Time Factors
  • Treatment Outcome

Substances

  • Drug Combinations
  • HIV Protease Inhibitors
  • Pyrimidinones
  • RNA, Viral
  • Lopinavir
  • Ritonavir